ONCT - Oncternal Therapeutics Inc. (ONCT) Q4 2023 Earnings Call Transcript
2024-03-07 20:46:07 ET
Oncternal Therapeutics, Inc. (ONCT)
Q4 2023 Results Conference Call
March 07, 2024 05:00 PM ET
Company Participants
Richard Vincent - CFO
Dr. James Breitmeyer - President and CEO
Dr. Salim Yazji - Chief Medical Officer
Conference Call Participants
Carl Byrnes - Northland Capital Markets
Hartaj Singh - Oppenheimer
Kemp Dolliver - Brookline Capital Markets
Presentation
Operator
Greetings, and welcome to Oncternal's Fourth Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Richard Vincent, Chief Financial Officer. Thank you, Richard. You may begin.
Richard Vincent
Thank you, Alicia. Good afternoon, everyone, and thank you for joining us today. Joining me on the call this afternoon are our President and CEO, Dr. James Breitmeyer; and our CMO, Dr. Salim Yazji. Today's call includes a business update and discussion of our results for the fourth quarter and full year 2023....
Oncternal Therapeutics, Inc. (ONCT) Q4 2023 Earnings Call Transcript